New exhibit takes Urban Arts Space visitors ‘Behind the White Coat’ – Columbus Alive

Elizabeth Auckleys early interest in science convinced her she wanted to become a doctor, but she also loved visual art. Auckley took painting classes in high school, and in college at Ohio State, she added an art history major while taking pre-med courses. It scratched the arts itch a bit, but she didnt create anything herself duringthose undergrad years.

Auckley remained at Ohio State for medical school, and it was there she discovered Humanism in Medicine, a student-led organization that recognizes the humanities as an essential part of medical practice studies.

I think medicine is an art in itself, so having some kind of artistic background, it really becomes part of your medical practice, said Auckley, a third-year student at OSUs College of Medicine. Thinking about medical education, it's such a jam-packed four years, and there's a lot to learn here. It's a very rigorous curriculum, so there's always the argument that if you're adding in humanities education, are you taking out some valuable science portion?

A lot of the 20th century medical education ideas about medicine removed the humanities aspect and just focused on diseases as an organ system, separating the personalization of disease. Now, we think that really was not the right way to do things. So the focus of the 21st century is moving medicine back to more of a balance keeping the humanities side of personalization and deconstructing the hierarchy of the physician-patient relationship.

Through Humanism in Medicine, Auckley met Phillip Anjum, a fourth-year medical student, videographer and photographer. Anjum approached Auckley with a collaborative concept. His idea was to take portraits of our classmates in a setting outside of medicine, showing how they like to spend their time, what they identify with as a person, not as a medical student, said Auckley, who would then add paint to Anjums canvas-printed, black and white photos. "He wanted me to paint the color back in over the prints as a symbol of the personalization and the complexity of each person, really highlighting who they are outside of medicine.

From 2020 through March of 2022, Auckley and Anjum worked together on the project, and today (Tuesday, April 26), theircollaboration debuts at OSUs Urban Arts Space Downtown. Titled Behind the White Coat, the exhibition runs through May 7.

Anjum and Auckley wanted to use translucent layers of paint, a technique that usually calls for watercolor, which doesnt work well on canvas. So instead, Auckley tried a new method of thinning oil paint to create a similar effect. I ended up putting washes on each portraitin the style of watercolor, but with oil paint, she said. There's an old saying that your painting is only as good as the drawing. Painting is really my love; I'm OK at drawing, but it's not what I love to do. This project took away the drawing aspect. I was basically given a stencil Phil's beautiful photographs.

The project also gave Auckley newfound confidence and a reignited fire for making art, even during medical school. I really didn't think that I would come back to art [now]. I thought it probably would be later down the line when I have more time in my career or when I retired, she said. Having it in a gallery like this is unimaginable. … I'm glad I got some courage built up in me to do it.

Auckley also hopes the exhibition, and the ideas behind it, can benefit other students and the medical profession as a whole. Physician burnout and stress a lot of that arcs back to how your medical school experience was, she said. We hope that by showing these portraits, we can encourage people to live their lives as who they are and still enjoy their hobbies and their personal lives and families and friends, and realize that's a part of everyone's lives and not something that you have to hide.

See more here:
New exhibit takes Urban Arts Space visitors 'Behind the White Coat' - Columbus Alive

Hormones may explain link between excess weight and endometrial cancer – Medical News Today

Endometrial cancer is the most common cancer affecting the female reproductive tract in high-income countries. In the U.K., one in 36 women are estimated to be diagnosed with endometrial cancer in their lifetime.

Research has indicated that women with a high BMI are more at risk of developing endometrial cancer.

BMI is calculated using a persons height and weight and is used to determine if a persons weight is within a healthy range. A BMI score of 20-25 is considered healthy, a BMI over 25 is considered overweight, over 30 is considered obese, and over 40 is considered severely obese, as accepted by the NHS. BMI is an indirect measure of fat tissue and it is less accurate in some individuals, hence remains controversial.

Dr. Sarah Gray, a general practioner who specializes in womens health, told Medical News Today in an interview that 20 years ago she worked on developing guidelines at The National Institute for Health and Care Excellence (NICE) for women with heavy periods, which can be a symptom of endometrial cancer. The guidelines concluded that the chance of getting uterine cancer below the age of 45, was really very remote.

She explained that as rates of obesity had increased in the population, this had changed:

Ive got a colleague who is now occasionally seeing uterine cancer in women in their early 30s, she said.

Now, a study published in BMC Medicine has quantified the increase in the risk of endometrial cancer in women with a high BMI and has proposed a mechanism for the link.

A team led by researchers from the University of Bristol, with support from Cancer Research U.K., carried out an analysis of genetic samples and health information taken from the Endometrial Cancer Association Consortium, the Epidemiology of Endometrial Cancer Consortium, and the U.K. Biobank.

Of the 121,885 women largely of European descent (from Australia, Belgium, Germany, Poland, Sweden, the U.K., and the U.S.) included in this study, 12,906 of these women had endometrial cancer.

They found an increase of 5 BMI points was associated with an 88% increase in risk of developing endometrial cancer.

They also discovered that increased testosterone, increased fasting insulin, and decreased sex hormone-binding globulin were associated with an increase in the risk of developing endometrial cancer.

Further analysis by the researchers also found evidence that BMI had an effect on fasting insulin, sex hormone-binding globulin, bioavailable testosterone, and the inflammatory marker C-reactive protein.

The authors hypothesize that increased BMI indicated increased fat tissue, which leads to increased fasting insulin and reduced sex hormone-binding globulin. This, in turn, leads to increased bioavailable testosterone. This testosterone can then be converted into estrogen, which may also increase the risk of endometrial cancer.

Dr. Alpa Patel, senior vice president of population science at the American Cancer Society, explained the link between BMI and endometrial cancer risk wasnt necessarily a new one.

We do know that especially in visceral fat that surrounds an organ, [which] is quite metabolically active, [that] is what increases your risk of both insulin resistance and hyperinsulinemia or higher levels of insulin, which can affect endometrial cancer risk, she told MNT.

Dr. Patel also touched on how menopause and hormonal changes may affect cancer risk.

After menopause, in fat cells themselves, you have conversions, of androgen (such as testosterone) to estrogen through an enzyme called aromatase. And that [ultimately] increases the conversion to different types of estrogen, and estradiol, which increases your risk of endometrial cancer because it is a hormone-related cancer in women. Dr. Alpa Patel

Dr. Patel said there was a direct link between excess body weight after menopause, owing to the increases in the conversion of androgen to estrogen, which can also increase the risk of endometrial cancer.

So, its not the androgens like testosterone alone. Its the increased conversion of those to estrogen through aromatase after menopause, she added.

Dr. James Yarmolinsky, the lead author of the study from the University of Bristol Medical School, explained to MNT how the study could influence clinical practice.

We try to understand mechanisms. This potentially opens up the possibility of targeting these particular molecules implicated, so mainly insulin and testosterone, he said.

[There are] medications like metformin, for example, which we know can increase insulin signaling. [T]hey help in the management of type 2 diabetes, which, in principle, potentially, could be repurposed in some way for endometrial cancer chemoprevention, he suggested.

Dr. Yarmolinsky said that the findings alone couldnt say whether this was a viable approach but it was a first step in the right direction.

Dr. Gray, meanwhile, said the studys findings could prompt women with a high BMI to be more aware of the symptoms of endometrial cancer, so they seek medical help in a timely manner.

Women who are particularly obese need to be able to monitor their periods. If they go chaotic, erratic, or heavy, then the test is ever so simple. Its going to be an ultrasound and/or a sample taking, she said.

See the article here:
Hormones may explain link between excess weight and endometrial cancer - Medical News Today

Carolyn Meltzer bringing integrity, a collaborative spirit, and a sense of service to taking on the toughest health challenges | Keck School of…

The new Dean sees Keck School of Medicine of USC as uniquely positioned to lead the health care innovation of tomorrow with its academic excellence and diverse urban community.

By Laura LeBlanc

Coming up through the ranks in medicine over the last three decades, Carolyn Meltzer has been part of great change, both in her areas of specialty, neuroradiology and nuclear medicine, and in the culture of medicine itself. As the new Dean of the Keck School of Medicine of USC, she sees the opportunity for the school to play a leading role in driving the innovations needed in health care now to take on the toughest diseases and make the system equitable and accessible.

Prior to joining USC, she was at Emory University School of Medicine, serving as Chair of the Department of Radiology and Imaging Sciences, the Executive Associate Dean for Faculty Academic Advancement, Leadership and Inclusion, and the William P. Timmie Endowed Professor. We sat down with her to talk about where shes been and where see sees the Keck School going.

When did you realize you wanted to go into medicine?

I was good at math and science and from high school on I was always intrigued with the brain how it works, the connections between biology, neurobiology and our cognitive selves. So, I thought I would become a scientist. My dad, a Greek immigrant, would always say consider medicine. I had worked in many laboratories and knew I was excited about research. But I thought, What if I turn out to be a terrible doctor? Still, secretly I let myself think about it. In college I got involved in a group called Women in Medicine where I was exposed to speakers who were physicians and women role models and decided that was the way to go.

What drew you to neuroradiology, medical imaging focusing on abnormalities of the brain, spine, head, and neck?

When I did my clinical rotation in neurology at medical school, I was with a chief resident at the county hospital and all he wanted to do was go look at the imaging. He kept saying, There are so many cool things. And really, we cant diagnose a lot without the imaging. Then I did some research in neuroimaging, in PET imaging, and thought, This is what I want to do. The problem solving, the spatial piece, the technology neuroradiology combines all of it. I love technology and being challenged with things innovating constantly.

Youve mentored more than 70 undergraduate and graduate students. Why is mentoring important to you and what do you gain from it?

I was a first-generation college and medical student. I had no idea what I was doing. I had people who spent time with me, supported me, who taught me things that other students were much more prepared for. And thats had such an impact on my life as well as my career. For me, its about giving back. But I also feel I continuously learn from my mentees, the questions they ask, which helps me evolve in how I approach them.

How has your experience coming up through the ranks in the medical field informed your approach to creating a culture of diversity, inclusion and equity?

When I went to medical school, only about a third of my class were women. And there was this deeply embedded culture, of very traditional, systemic, second-generation gender bias. Not to say we didnt have a lot of really supportive people. But basically, there was a masculinity in all of the terminology, how strong you could be, how tough you could be. As I got more comfortable with who I was in medicine and what I was pursuing, I was more able to be my authentic self. And thats really important. I think with folks who are identified with groups that are historically underrepresented in medicine, theres this sense of code switching where you have to be a certain self at work and then you can be more comfortable at home. Considering that is this an institution where people feel like they can be their authentic selves, where they feel like they belong is part of the inclusion piece, of creating an inclusive climate.

What three words best describe your leadership style?

Collaborative Im not afraid to make decisions, but I really want a lot of input. I know Ill make better decisions if I have a diverse team of people who bring different experiences and feel comfortable speaking up. Integrity values-based leadership is really important to me. As a leader you need to know where your own red line is, your own sense of whats right and wrong, to ensure the decisions you make are true to it. Finally theres a servant aspect. Servant leadership means when you agree to lead, you agree to serve others.

What excites you most about your new role as dean here?

The opportunity for positive impact. The people here are incredible. Together with the investments and the strategic focus that President Folt has set forward with Steve Shapiro, theres an extraordinary opportunity for us, uniquely as an institution, to address some complex problems in health care. Our connection with the community in one of the most diverse urban areas in the world allows us to work with those we serve to find solutions to the tough problems improving treatments for complex disease, mitigating the effects of climate change,

Imaging is not only your vocation its also your art and your work has been featured in about 60 exhibitions in the US and Europe. Has it influenced the way you approach medicine or research?

Obviously, its related in terms of the medium, but I think its more about spending time doing something separate from medicine. Also feeling comfortable showing my work and saying, Yes, Im a physician. Yes, Im a photographer. I dont have to be one or the other. Ill tell you a funny story I was once on a flight to a medical meeting in Beijing and I had brought my tripod, all my equipment. The flight attendant helped me put my tripod in the bin and he said, Oh, are you a photographer? I said, Yes. And we chatted a little bit about photography. Then somebody got sick on the plane, and they called for a doctor, and I got up and he said, I thought you were a photographer.

Tell us about your family. I understand youre a dog person and that one of them can read!

My husband and I have four rescue dogs. Weve been doing rescue work for a long time. Neither of us has the ability to say no to the other when one wants to bring an animal home. Ive had two therapy dogs and worked with them in all kinds of settings a school for the blind, childrens hospitals, nursing homes. Library programs have been particularly rewarding. Its easier for a child to feel comfortable reading to a furry cuddly dog than to an adult who may be correcting them. So, I always say, My dog can read, so do you want to read with him? And theyll read together. But COVID made my therapy dog fat and lazy. He couldnt go into libraries for two years. Now he just wants to lie on the couch.

Follow Dean Meltzer on Twitter@DeanMeltzerand Instagramdeanmeltzer_keckschool.

Read the original here:
Carolyn Meltzer bringing integrity, a collaborative spirit, and a sense of service to taking on the toughest health challenges | Keck School of...

Statement by Dr. Yaron Rado, Chief Radiologist and Chairman of the Board of Doctors Hospital on Cayman Court Judicial Review challenging concessions…

GEORGE TOWN, Cayman Islands, April 27, 2022 /PRNewswire/ -- Dr. Yaron Rado, Chief Radiologist and Chairman of the Board of Doctors Hospital, issued the following statement regarding the three-day judicial review, Grand Court Cases Nos 55 and 150 of 2021 challenging Institutionally registered medical professionals practising in Cayman and the financial concessions awarded to them.

"To set the scene:

Unlike doctors on the Principal List, the Health Practice Regulations don't require institutionally registered doctors to have any postgraduate qualifications or any special training. Institutional List practitioners need only have obtained their qualifications from almost any medical school in the world (vs Principal List providers who must be registered from one of seven countries: Australia, Canada, Jamaica, New Zealand, South Africa, United Kingdom, and the United States).

They are also not required to provide proof of specialist qualifications to call themselves a specialist or consultant, let alone a proper residency program (5 years), a fellowship program (an additional two years), and then three years of post-specialisation experience as required for the Principal List.

The only safeguard for patients to date is that institutionally registered doctors must practice at a "designated facility" and that Cabinet is responsible for designating these facilities.

Of course, the problem is that until April 6 2022, the Cabinet did not require facilities to meet any particular criteria before designating them, and Cabinet has no record of why Health City, Total Health, and Aster DM were designated as such. Cabinet has also not produced any criteria for reviewing the designation of facilities. In other words, there has been nothing to stop facilities from employing inexperienced Institutional List doctors with minimal supervision.

Until this court hearing, the concern had repeatedly been expressed by the local medical community that doctors on the institutional list were subject to a far lower level of regulation than doctors on the principal list, with consequent concerns for patient safety. This meant that doctors could be registered to practice here as institutional list practitioners with potentially very limited experience and qualifications.

On day 2 of the JR hearing, however, the Government's QC stated that, on the Governments interpretation of the legislation, all doctors must possess the same or equivalent level of qualification and experience for registration. He stated that this is because Regulation 5 of the Health Practice Regulations is applicable to institutional list doctors as well as principal list doctors. On day 3 of the JR hearing, the Government's QC once more confirmed that this is the correct interpretation of the law, and the interpretation the government applies in regulating the institutional list.

We must await Justice William's judgment to find out whether he will record that this new construction of the health practice law and regulations is correct, and must be applied going forwards, or whether he will instead recommend that the position is clarified by amending the legislation. Either way, the Government's formal position, as articulated in court last week, means that all doctors registered to practice in Cayman must now possess an appropriate, minimum level of qualification and experience. As such, Regulation 5A, and the "second-tier" institutional list (initially introduced by the Health Practice law (2013 revision), will effectively be abolished."

Of these two Grand Court Cases Nos 55 and 150 of 2021 in the Cayman court, this is a huge win for healthcare in Cayman - and for all duly regulated Principal List practitioners after years of dedication and investment into their education in compliance with the Health Practice Act and under the supervision of the Medical and Dental Council (MDC). I want to express my sincere appreciation for our lawyers Sally Bowler, Chris Buttler, and Ben Tonner from McGrath Tonner, who have worked tirelessly on our behalf to help affect these changes.

Unfortunately, all Institutional List physicians with boots on the ground in Cayman are exempted from meeting Principal List standards. Thankfully, the Cayman Islands Medical and Dental Society (CIMDS) has recently launched the "Green Tick" campaign to raise awareness about healthcare providers' two separate registration lists. We invite the people of the Cayman Islands to educate themselves so they can make informed healthcare choices for their families. We also ask our Government to strongly reconsider their position on this matter as each existing Institutional List provider renews their registration (every two years). They should be held to the same medical standards, values, and code of ethics we Principal List providers stand behind for our patients.

At this juncture, only half the battle is won.

The Government has a discretion under the various laws to waive the duties payable by healthcare facilities, indeed by anyone. However, there is currently no transparent, published guideline or criteria assisting those liable to pay these duties to understand when they will or won't be eligible for a waiver or an exemption: meaning that there is currently no transparent benchmark for obtaining a duty waiver or exemption. Health City (both in the east end and at its current and forthcoming Camana Bay facilities) receives huge financial privileges in the form of stamp duty waivers, import duty exemptions and discounts on work permit fees. This is all predicated on a contract that it entered into with the Government in 2010.

By comparison, Doctors Hospital paid CI$ 1.2 million in stamp duty to acquire its current site and has spent more than CI$ 1 million in customs duty alone over the last three years. Yet 12 years later Health City's medical tourism facility, at least as the 2010 contract envisioned it to be, namely, an integrated hospital comprising of a hospital, medical university and an assisted living facility, has not materialized. So why are these concessions continuing to be granted?

Doctors Hospital is concerned about this lack of transparency and the lack of any regulatory framework which ensures fairness. As a result, Doctors Hospitals seeks a declaration that transparent criteria for the granting and refusal of concessions ought to be published for all to see.

Doctors Hospital has the same interest as any other taxpayer in the lawfulness of the Government collecting taxes and believes it is unlawful for the Government to grant waivers to Health City and others on the premise that it is now contractually bound to do so. In particular, when the public is losing out on large sums of money that would be available for public services.

Doctors Hospital's motivation in bringing this judicial review is to, first and foremost, promote and preserve the integrity of healthcare in Cayman and to ensure that the Cayman Islands Government provides a fair and transparent tax system for all.

The ultimate findings from this three-day judicial review will be revealing. I sincerely hope that patient safety and the highest principles of healthcare are fully realised and that we bring an end to a long list of discriminatory concessions that Health City's arrival in the Cayman Islands has brought about."

SOURCE Doctors Hospital

See original here:
Statement by Dr. Yaron Rado, Chief Radiologist and Chairman of the Board of Doctors Hospital on Cayman Court Judicial Review challenging concessions...

Bethel University Builds on Commitment to Service With New Program for Aspiring Healthcare Workers – Yahoo Finance

In partnership with Tiber Health, Bethel University launches a new Master of Science in Medical Sciences (MSMS) program to help create a pipeline for aspiring healthcare workers in Minnesota.

ST. LOUIS, April 25, 2022 /PRNewswire/ -- Bethel University has announced a new Master of Science in Medical Sciences (MSMS) program, powered by Tiber Health, expected to launch in the fall of 2022. The MSMS program will build off of Bethel's longstanding commitment to changing the world through service and leadership by providing recent college graduates with pathways into careers in medicine and MD programs.

Tiber Health

The MSMS program at Bethel University will be the first of its kind in Minnesota and provides a unique solution for addressing the state's critical healthcare worker shortage by offering a pathway for aspiring medical professionals to pursue careers in medicine. As the state of Minnesota has grown rapidly over the last decade particularly amongst populations of color the healthcare workforce has failed to keep pace, in part due to massive departures of healthcare workers during the pandemic that left the state in such dire need for talent that it had to enlist the support of teams of doctors and nurses from the U.S. Department of Defense.

"Throughout our university's history, we have prioritized preparing the next generation of leaders in their churches, workplaces, and communities. As we think about the needs of our state when it comes to building safe, healthy environments, this new partnership is a natural advancement of our existing healthcare program offerings and will help ensure our students can serve their communities in a multitude of ways," said Chad Osgood, Dean of Business, Leadership, Health, and Social Sciences at Bethel University. "We are delighted to see this program come to life and look forward to watching our students impact change in their communities for years to come."

Story continues

Over the last 30 years, Bethel has seen rapid growth, growing to over 4,000 students and offering over 100 degree options, including a number of options in the health sciences. Currently, Bethel University offers pre-medicine and healthcare tracks that help prepare students for careers in healthcare. Students interested in medicine often pursue a bachelor's in athletic training, biokinetics, biology, biochemistry, and nursing. Bethel also provides Physician Assistant and Nurse-Midwifery master's programs.

The new MSMS program will give students the chance to further develop their professional skills and prepare them to pursue graduate-level programming leading to an MD or in-demand career. Through this new MSMS offering, the top 20% of the students applying for admissions to Ponce Health Sciences University (PHSU) medical school will be given an interview, eliminating potential barriers for students who may be interested in becoming physicians.

The MSMS program, powered by Tiber Health with a curriculum delivered by the faculty at PHSU, is a 42-credit master's degree program that provides students an accessible, affordable way to experience medical school. The MSMS model was developed at PHSU and has been successfully implemented at schools across the country, yielding impressive pass rates on the USMLE Board Step 1 exam. The MSMS program blends virtual and in-person customized learning and utilizes advanced analytics to guide student performance and predict performance in medical school and the Step 1 exam.

"Minnesota is a state long known for its exemplary healthcare offerings. As we think about the increased need for robust pipelines where aspiring medical professionals from diverse backgrounds can pursue a career in medicine, very few states are more ripe for this type of programming than Minnesota," said Dr. David Lenihan, president of Ponce Health Science University and co-founder and CEO of Tiber Health. "We are pleased to partner with Bethel University and know this is only the start of a new journey for Bethel students interested in giving back to their communities through medicine."

About Bethel UniversityAt Bethel University, we're called to more. We believe God is calling us to accomplish incredible things. In our Christ-centered community, we prepare whole leaders who own their faith, step into the world with boldness and confidence, and act with integrity as they answer God's call to do and be more. With top-ranked academics, engaged faculty, and experiential learning opportunities, we'll equip you to make a kingdom impactfor God's glory and your neighbors' good.

About Tiber HealthTiber Health is scaling exceptional medical education to bring more healthcare workers to the places that need it the most. The rigorous curricula, predictive data analytics, and focus on cultural competency aspects of healthcare are transforming the way health science is taught and learned. Tiber Health's large scale data is used to create more medical professionals at an effective rate, all while encouraging students to follow their dream career.

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/bethel-university-builds-on-commitment-to-service-with-new-program-for-aspiring-healthcare-workers-301531629.html

SOURCE Tiber Health

Go here to read the rest:
Bethel University Builds on Commitment to Service With New Program for Aspiring Healthcare Workers - Yahoo Finance

The Major Findings of Harvards Report on Its Ties to Slavery – The New York Times

In 2019, Harvards president, Lawrence S. Bacow, appointed a committee of faculty members to investigate the universitys ties to slavery, as well as its legacy. Discussions about race were intensifying across the country. Students were demanding that the names of people involved in the slave trade be removed from buildings. Other universities, notably Brown, had already conducted similar excavations of their past.

The resulting 134-page report plus two appendices was released Tuesday, along with a promise of $100 million, to create an endowed fund to redress past wrongs, one of the biggest funds of its kind.

Here are some of its key findings and excerpts.

The report found that enslaved people lived on the Cambridge, Mass., campus, in the presidents residence, and were part of the fabric, albeit almost invisible, of daily life.

Over nearly 150 years, from the universitys founding in 1636 until the Massachusetts Supreme Judicial Court found slavery unlawful in 1783, Harvard presidents and other leaders, as well as its faculty and staff, enslaved more than 70 individuals, some of whom labored on campus, the report said. Enslaved men and women served Harvard presidents and professors and fed and cared for Harvard students.

The committee found at least 41 prominent people associated with Harvard who enslaved people. They included four Harvard presidents, such as Increase Mather, president of the university from 1692 to 1701, and Benjamin Wadsworth, president from 1725 to 1737; three governors, John Winthrop, Joseph Dudley and John Leverett; William Brattle, minister of First Church, Cambridge; Edward Wigglesworth, professor of divinity; John Winthrop, professor of mathematics and natural philosophy; Edward Hopkins, founder of the Hopkins Foundation; and Isaac Royall Jr., who funded the first professorship of law at Harvard.

While New Englands image has been linked in popular culture to abolitionism, the report said, wealthy plantation owners and Harvard were mutually dependent for their wealth.

Throughout this period and well into the 19th century, the university and its donors benefited from extensive financial ties to slavery, the report said. These profitable financial relationships included, most notably, the beneficence of donors who accumulated their wealth through slave trading; from the labor of enslaved people on plantations in the Caribbean islands and in the American South; and from the Northern textile manufacturing industry, supplied with cotton grown by enslaved people held in bondage. The university also profited from its own financial investments, which included loans to Caribbean sugar planters, rum distillers, and plantation suppliers along with investments in cotton manufacturing.

Early attempts at integration met with stiff resistance from Harvard leaders who prized being a school for a white upper crust, including wealthy white sons of the South.

In the years before the Civil War, the color line held at Harvard despite a false start toward Black access, the report said. In 1850, Harvards medical school admitted three Black students but, after a group of white students and alumni objected, the schools dean, Oliver Wendell Holmes Sr., expelled them.

Harvard faculty members played a role in disseminating bogus theories of racial differences that were used to justify racial segregation and to underpin Nazi Germanys extermination of undesirable populations.

In the 19th century, Harvard had begun to amass human anatomical specimens, including the bodies of enslaved people, that would, in the hands of the universitys prominent scientific authorities, become central to the promotion of so-called race science at Harvard and other American institutions, the report said.

The bitter fruit of those race scientists remains part of Harvards living legacy today.

One of those race scientists was the naturalist and Harvard professor Louis Agassiz, who commissioned daguerreotype portraits of enslaved people Delia, Jack, Renty, Drana, Jem, Alfred, and Fassen in an attempt to prove their inferiority. The report does not mention that Tamara Lanier, a woman who has traced her ancestry to Renty, had challenged Harvards ownership of the portraits, saying that the images of Renty and his daughter Delia, taken under duress, are the spoils of theft.

Until as recently as the 1960s, the legacy of slavery lived on in the paucity of Black students admitted to Harvard.

During the five decades between 1890 and 1940, approximately 160 Blacks attended Harvard College, or an average of about three per year, 30 per decade, the report said. In 1960, some nine Black men numbered among the 1,212 freshman matriculants to Harvard College, and that figure represented a vast improvement over the prior decades.

See the original post:
The Major Findings of Harvards Report on Its Ties to Slavery - The New York Times

Millig Design Build President is Speaker at 2022 ISPE Biotechnology Conference on Sustainability in the Biopharmaceutical Industry – PR Newswire

Scott McVey, president of Millig Design Build, an expert in decarbonization, to speak at ISPE Biotechnology Conference.

"It's an honor to be invited to deliver this presentation at the ISPE Biotechnology Conference," said McVey. "The biopharmaceutical sector has bold, ambitious carbon reduction targets. This event is the perfect opportunity to share specific steps the industry can take now to achieve its Net Zero goals."

McVey's presentation will focus on the challenges the biopharmaceutical sector faces in achieving Net Zero carbon emissions; the technologies available today that can safely replace the fossil fuels the industry uses for electricity and manufacturing processes; and the steps the sector needs to take now to achieve Net Zero by 2050.

Unlike the majority of the manufacturing sector, where most energy consumption comes from process heat, 65 percent of energy consumption in the biopharmaceutical sector arises from stringent environmental conditioning requirements like indoor temperature, relative humidity, air change rate, room pressurization, filtration, and ventilation. Millig Design Build has developed a sequence strategy the biopharmaceutical sector can deploy to meet stringent environmental conditioning requirements and ensure safety and quality, while reducing Scope 1 and 2 carbon emissions associated with electricity and fuel use.

"As a design-build firm, Millig is uniquely positioned to decarbonize critical environments like those found in biopharmaceutical facilities," said McVey. "We deliver value far beyond a decarbonization plan. We provide an actionable roadmap for long-term decarbonization, and we're able to immediately design and install the solutions we identify during our initial analysis phase."

About Millig Design BuildMillig Design Build is an integrated engineering, design, and construction firm specializing in facility improvements that address energy efficiency, building health and safety, and core infrastructure needs. Our mission is to create environments that promote sustainability, wellbeing, and opportunity for communities while efficiently delivering best-value solutions for owners. We have offices in Kansas; Colorado; Oregon; Washington; and Vancouver, Canada. For more information, visit http://www.milligdb.com.

Media Contact Information:Amy McVeyMillig Design BuildPhone: 785-865-6054E-mail: [emailprotected]

SOURCE Millig Design Build

Read more:
Millig Design Build President is Speaker at 2022 ISPE Biotechnology Conference on Sustainability in the Biopharmaceutical Industry - PR Newswire

The Biotechnology Services Market Is Expected To Reach $267 Billion By 2026 Due To A Rapid Increase In Lifestyle And Chronic Diseases As Per The…

LONDON, April 21, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Companys research report on the biotechnology services market, the biotechnology services market is expected to grow rapidly due to increasing lifestyle and chronic diseases. This is mainly due to unhealthy lifestyles, a growing aging population, rising inactivity and obesity. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally by the year 2020. China and India together had about 193.4 million diabetic patients in 2019, and India is expected to have about 101 million diabetic patients by 2030. In the field of mental health, the World Health Organization predicts that one in every four people will beaffected by a type of mental disorder such as depression, schizophrenia, or anxiety in the future. In response to this, national governments across the globe are rapidly increasing their medical research expenditure. The world's population is also growing older with every passing year.

For instance, worldwide, the average life expectancy is expected to rise from 73 years to 74.1 years between 2016 and 2021. Based on this estimate, 11.5% of the world population will be over 65 years of age by 2021. Additionally, due to the increased consumption of processed foods, chronic health conditions like diabetes are expected to become more common. Therefore, increasing investment in medical research to treat chronic diseases is further driving the demand for biotechnology services.

The global biotechnology services market is expected to grow from $129.14 billion in 2021 to $151.10 billion in 2022 at a compound annual growth rate (CAGR) of 17.0%. The growth in the market is mainly due to companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. TBRCs biotechnology services market growth analysis states that the market is expected to reach $267.29 billion in 2026 at a CAGR of 15.3%.

Request for a sample of the global biotechnology services market report

The development of automated solutions for devices and equipment is gaining popularity among biotechnology services market trends. Automation of the process will help to enhance productivity and consistency of the whole diagnostic process, along with reducing contact points for samples, consumables, and liquid handling, which improves the safety of clinical and laboratory personnel. In 2019, Thermo Fisher Scientific, based in Massachusetts, USA, a major player in the market, introduced a new benchtop automated reading and incubation system for antimicrobial susceptibility testing (AST). This new instrument will provide microbiology laboratories with accurate minimum inhibitory concentration (MIC) results that are needed by clinicians to confidently select an effective antibiotic for critically ill patients while safeguarding future patient care through more successful antimicrobial stewardship.

Major players in the biotechnology services market are Novartis, Fisher BioService, Pfizer, Novo Nordisk, BioAlps, Precision for Medicine, Sartorius and Aldevron.

The global biotechnology services market segmentation is categorized by service into prevention and disease control, public engagement activities, health education and research, food biotechnology services, donor recruitment, tissue collection, cell processing and isolation, research and development; by industry into Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), Contract Research and Manufacturing Services (CRAMS); by area of application into pharmaceutical, biotechnological, academic, clinical trial, healthcare sectors.

As per the biotechnology services industry overview, in 2021, Asia Pacific was the largest region in the market. North America was the second largest region in the biotechnology services market. The regions covered in the biotechnology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Biotechnology Services Global Market Report 2022 Market Size, Trends, And Global Forecast 2022 2026 is one of a series of new reports from The Business Research Company that provide biotechnology services market overviews,biotechnology services market analyze and forecast market size and growth for the whole market, biotechnology services market segments and geographies,biotechnology services market trends, biotechnology services market drivers,biotechnology services market restraints,biotechnology services market leading competitors revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors approaches.

Not the market you are looking for? Check out some similar market intelligence reports:

Diabetes Care Devices Global Market Report 2022 By Type (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type Of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) Market Size, Trends, And Global Forecast 2022-2026

Biosimulation Global Market Report 2022 By Product (Software, Services), By Application (Drug Development, Drug Discovery), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Regulatory Authorities, Academic Research Institutions) Market Size, Trends, And Global Forecast 2022-2026

Laboratory Automation Systems Global Market Report 2022 By Equipment & Software (Automated Liquid Handling, Microplate Readers, Standalone Robots, Automated Storage And Retrieval Systems, Software And Informatics, Other Equipment), By Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions, Other Applications), By End User (Biotechnology And Pharmaceutical Industries, Research Institutes, Hospitals And Private Labs, Academic Institutes), By Type (Modular Automation, Total Lab Automation) Market Size, Trends, And Global Forecast 2022-2026

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The Worlds Most Comprehensive Database

The Business Research Companys flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Read the rest here:
The Biotechnology Services Market Is Expected To Reach $267 Billion By 2026 Due To A Rapid Increase In Lifestyle And Chronic Diseases As Per The...

PDS Biotechnology Co. (NASDAQ:PDSB) Given Consensus Recommendation of Buy by Analysts – Defense World

PDS Biotechnology Co. (NASDAQ:PDSB Get Rating) has been given a consensus rating of Buy by the eight research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $21.20.

Separately, StockNews.com upgraded shares of PDS Biotechnology to a sell rating in a research report on Saturday, April 9th.

NASDAQ:PDSB opened at $5.16 on Monday. The firms 50 day simple moving average is $5.95 and its 200 day simple moving average is $7.99. PDS Biotechnology has a one year low of $4.10 and a one year high of $17.85.

Large investors have recently added to or reduced their stakes in the company. Voloridge Investment Management LLC increased its stake in shares of PDS Biotechnology by 279.2% in the 3rd quarter. Voloridge Investment Management LLC now owns 49,191 shares of the companys stock valued at $733,000 after acquiring an additional 36,219 shares in the last quarter. Trexquant Investment LP bought a new stake in shares of PDS Biotechnology in the 3rd quarter valued at $632,000. Cubist Systematic Strategies LLC increased its stake in shares of PDS Biotechnology by 187.0% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 71,618 shares of the companys stock valued at $1,067,000 after acquiring an additional 46,665 shares in the last quarter. Jump Financial LLC bought a new stake in shares of PDS Biotechnology in the 3rd quarter valued at $393,000. Finally, Valeo Financial Advisors LLC increased its stake in shares of PDS Biotechnology by 35.7% in the 4th quarter. Valeo Financial Advisors LLC now owns 21,570 shares of the companys stock valued at $175,000 after acquiring an additional 5,670 shares in the last quarter. Institutional investors own 23.91% of the companys stock.

PDS Biotechnology Company Profile (Get Rating)

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer.

Featured Stories

Receive News & Ratings for PDS Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PDS Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.

Read more:
PDS Biotechnology Co. (NASDAQ:PDSB) Given Consensus Recommendation of Buy by Analysts - Defense World

Master of Science in Biotechnology and Bioinformatics at IBAB Bengaluru – Mathrubhumi English

Institute of Bioinformatics and Applied Biotechnology (IBAB), Biotech Park, Electronics City Phase I, Bengaluru 560 100 has invited applications for admission to the 2 years Master of Science in Biotechnology and Bioinformatics Program 2022-24.

The MSc programme in Biotechnology and Bioinformatics is an interdisciplinary programme that positions one at the cutting edge of basic and applied science, in particular in the research field and a unique dual specialization degree programme that builds competence in both biotechnology and computational biology/ bioinformatics.

Students of this programme are provided extensive training in cell and molecular biology, genome editing, computer science, mathematics, statistics, bioinformatics and so on. Right from the beginning, the faculty ensures that the students get an immersive high quality research experience. They also get several opportunities to meet and interact with high-profile scientists from across the globe. Events such as the annual Kiran Mazumdar-Shaw Lecture series have enabled the visit of a Nobel laureate.

Eligibility: Applicant should hold Bachelors degree in any branch of science/technology/medicine such as Life sciences (zoology, botany, genetics, human biology, general life sciences, ecology, environmental biology), bioinformatics, biotechnology, chemistry, physics, mathematics, statistics, any branch of engineering, pharmaceutical sciences, agriculture, medicine, dentistry, horticulture, forestry and veterinary sciences, with degrees such as BSc, BE, BTech, BPharm, MBBS, BDS and BVSc etc. Applicant should have obtained at least 50% marks overall in Bachelors programme. There is no age bar for applying. Applicants who have had a break in their education or have been working for a few years are also eligible. Indian nationals, NRIs and foreign nationals who have passed the qualifying degree examination outside of India, must submit the Equivalence Certificate issued by the Association of Indian Universities along with their application.

Applicants will be short listed based on a proctored online examination. The details will be intimated later. The entrance test to the MSc in Biotechnology and Bioinformatics (20222024) will cover the subjects Physics, Mathematics, Chemistry, and the Life sciences. The details of the syllabus and pattern will be updated on the web page. Any change in the examination pattern will be intimated to the applicants.

The short listed candidates will be interviewed either in person at IBAB, or in online mode. Candidates will be intimated in due course about the date and mode of interview.A scholarship will be awarded based on the performance of the student each year, and the financial need of the student.

Application can be submitted online through the link available in the Program Notification at Announcements link at https://www.ibab.ac.in/ latest by 7.5.2022.Application fee is Rs. 600/-. Mock test (online, can be taken from anywhere) will be held on 15 May 2022. Entrance Test (online, proctored) will be conducted on 22 May 2022. Personal Interview will be between 06 June-16 June 2022. Course Commences on 18 July 2022. For details, visit https://www.ibab.ac.in/

Visit link:
Master of Science in Biotechnology and Bioinformatics at IBAB Bengaluru - Mathrubhumi English

Ukraine war exposes EU’s organic obsession and biotechnology rejectionism – Genetic Literacy Project

Beyond needless loss of life, the war in Ukraine has caused a trade war that could slash global food production, taking the greatest toll on the poorest of us. The silver lining: this tragic situation may inspire some long-overdue policy reforms.

The world is in a precarious place. Besides the fact that several thousand people have already been killed and millions more displaced, the war in Ukraine has triggered a trade war that could do severe damage to farmers and consumers around the world. A handful of wealthy celebrities have celebrated this development, urging the rest of us to endure skyrocketing gas and food prices if it means putting the screws to Putin, as Stark Trek actorGeorge Takeiso unhelpfully put it.

Comments like that play well on Twitter, but they ignore two important points everybody should recognize. Vladimir Putin wont miss any meals because of the economic measures aimed at Russia, but lots of poor people worldwide will go hungry. If there is an upside to this war, its that the subsequent food price hikes and shortages have exposed the folly of Europesprotectionistanti-GMO policies.

Russia and Ukraineproduce just over30 percent of the worlds wheat. Dozens of developing countries count on those exports to feed themselves, and they could suffer devastating consequences if the war and resulting economic sanctions continue to disrupt global trade.

Retired US Army Colonel Douglas MacGregorrecently pointed outthat the Russian army has so far avoided the center of Ukraine, where most of the countrys crops are grown. Thats important over the long term, though farmers may not be able to plant anything this year. Even if they get crops in the ground, their production will be limited because the seed, fertilizer, fuel, and other inputs they need wont be delivered with Russian troopssurroundinga major port city like Mariupol, where a lot of imported goods enter Ukraine.

This is concerning since the United Nations World Food Program (WFP),which helps combat food insecurity primarily in northern African countries, buys about half its wheat from Ukraine. The WFP will either have to pay higher prices to other wheat exporters or buy less grain, and that could mean millions or potentially tens of millions more people transitioning into food insecurity, University of Saskatchewan agricultural economistStuart Smythtold ACSH during a recent interview.

The situation in Russia could have a similarly troubling impact. A few weeks ago, the country got skittish about the quick pace of its grain exports to neighboring ex-Soviet countries,Reuters reported, and moved to slow it down to protect the domestic food market in the face of external constraints, primarily Western sanctions.

That means higher grain prices globally, but the ensuing trade war will have further effects. Russiahas slashedexports of fertilizers that growers around the world depend on. Brazila major exporter of soybeans, coffee, and sugarwas already having trouble acquiring all the crop nutrients it needed before the war broke out. Exacerbated shortages will likely further inflate the prices of these commodities.

And because Russia is home tolarge mineral depositsfound in few other parts of the world, replacing the countrys fertilizer output could take several years, if its even possible. Argentina, another agricultural powerhouse, hascapped soy and corn exportsto shield its population from higher food prices in response to the fertilizer shortage, economist David Stockman noted last week. Overall, were talking about double-digit increases. As Olivier de Matos, director-general of CropLife Europe,wrote on March 17:

Escalating food prices that are already plaguing consumers around the world look set to get much worse. The United Nations has warned that already record global food costs could increase by a further 22% as the war stifles international trade and decimates future harvests.

Before Russian tanks rolled into Ukraine, The European Union was poised to implement its Farm-To-Fork program, whichaimed tocut pesticide use by 50 percent and commit 25 percent of Europes farmland to organic food production by 2030. This was alwaysa misguided plan; now its a pipe dream, and the EU knows it. Policymakers areworking to relaximport restrictions on transgenic (GMO) crops that farmers need for animal feed, an increase beyond the30 million metric tonsof genetically engineered soy Europe already imports.

This is a positive step in the grand scheme of things, and it may finally push Europe into letting farmers grow the biotech crops its regulators knowpose no riskto human health or the environment. It gives governments an opportunity to take a hard look at the underlying rationale for prohibiting GM crop cultivation in the first place, Smyth added. I think some governments are going to say, That time has passed, and we need to change our policies.

Heres to hoping the EU takes Smyths adviceand that this war comes to an end sooner rather than later.

Cameron English is a writer, editor and co-host of the Science Facts and Fallacies Podcast. Before joining ACSH, he was managing editor at the Genetic Literacy Project, a nonprofit committed to aiding the public, media, and policymakers by promoting science literacy. You can visit Camerons website here

A version of this article was posted at American Council on Science and Health and is used here with permission. You can check out the American Council on Science and Health on Twitter @ACSHorg

Read the original post:
Ukraine war exposes EU's organic obsession and biotechnology rejectionism - Genetic Literacy Project

Synthetic Biology Market Size Worth $37.85 Billion, Globally, by 2028 at 20% CAGR – Exclusive Report by The Insight Partners – Yahoo Finance

NEW YORK, April 26, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Products (Enzymes, Chassis Organisms, Oligonucleotides, and Xeno-Nucleic Acids), Technology (Measurement & Modeling, Cloning & Sequencing, Genome Engineering, Gene Synthesis, Nanotechnology, and Others), and Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications, and Others)", the global synthetic biology market is expected to grow from $10.54 Billion in 2021 to $37.85 Billion by 2028; it is estimated to grow at a CAGR of 20.0%from 2021 to 2028.

The_Insight_Partners_Logo

The synthetic biology market growth is driven by the increasing investments in synthetic biology, advancements in biotechnology, and the rising number of start-ups. However, renewed regulations for biotechnology are restricting market growth.

Get Exclusive Access to Sample Pages of Synthetic Biology Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPHE100000960/

Report Coverage

Details

Market Size Value in

US$ 10.54 Billion in 2021

Market Size Value by

US$ 37.85 Billion by 2028

Growth rate

CAGR of 20.0% from 2021 to 2028

Forecast Period

2021-2028

Base Year

2021

No. of Pages

217

No. Tables

111

No. of Charts & Figures

84

Historical data available

Yes

Segments covered

Products, Technology, and Application

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Synthetic Biology Market: Competitive Landscape and Key Developments

In August 2021, New England Biolabs announced the release of its newest loop-mediated is sthermal amplification (LAMP) products: the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix (with UDG) and the WarmStart Fluorescent LAMP/RT-LAMP Kit (with UDG), which combines the master mix and LAMP fluorescent dye in one convenient kit. The new master mix and kit enable researchers to perform rapid, high-throughput detection of targeted segments of DNA or RNA using various amplification detection methods.

In April 2022, Agilent Technologies Inc. announced the expansion of CE-IVD marking in the European Union for its PD-L1 IHC 28-8 pharmDx as an aid in identifying esophageal squamous cell carcinoma patients for treatment with Bristol Myers Squibb's PD-1-targeted immunotherapeutic OPDIVO (nivolumab), in combination with fluoropyrimidine and platinum-based chemotherapy or OPDIVO in combination with YERVOY (ipilimumab). These combined treatments provide new hope for patients diagnosed with these cancers.

Story continues

In April 2022, Merck KGaA launched the first-ever antibody to achieve ACT label designation. ZooMAb antibodies received the lowest Environmental Impact Factor (EIF) scores in the chemicals and reagents category.

Place Your Inquiry Before Buying: https://www.theinsightpartners.com/inquiry/TIPHE100000960/

Global synthetic biology market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for synthetic biology. Asia Pacific is expected to account for the fastest global synthetic biology market growth.. Asia-pacific region will have lucrative growth opportunities during the forecast period due to government initiatives taken in the region. For instance, in November 2017, China launched the first synthetic biology association to support the market's growth. This association promotes academic research and communication in synthetic biology; it further enhances the comprehensive competitiveness of the Shenzhen synthetic biology industry and domestic and foreign influence. While, North America has huge market potential, followed by Europe in the overall synthetic biology market, which is attributed to government funds, investments made by the major companies, conferences held for the awareness regarding synthetic biology, technological advancements in the field of genomics, and higher acceptance by the consumers. However, the MEA and SCAM will also show a relatively lower opportunity in the next few years.

Synthetic biology is an emerging concept that has numerous applications in the chemicals, agriculture, pharmaceuticals, and energy industries. Various start-ups offer gene synthesis products/services for biological processes. For example, Benchling provides CAD tools, GenScript offers gene synthesis, Ginkgo Bioworks assists in organism engineering, Transcripts (a bioinformatics company) offers solutions facilitating cloud labs/automation, and Glowee offers consumer products. Further, 56 synthetic biology businesses raised more than US$ 3 billion in equity financing in the first half of 2020, compared to 65 companies raising US$ 1.9 billion during the same period in 2020. The new generation of biopharma businesses uses synthetic biology to improve cell treatment and gene therapy and support early cancer detection. Some synthetic biology firms with the most funding in the first half of 2020 are listed below.

Table 1. Synthetic Biology Firms with Most Funding in First Half of 2020

Company

Description

Funding

Sana Biotechnology

Biotechnology, Health Care, Life Sciences, and Product Research

US$ 700 million

Impossible Foods

Food & Beverage and Nutrition

US$ 500 million

Moderna Therapeutics

Biotechnology, Genetics, Health Care, Medical, and Pharmaceutical

US$ 483 million

Apeel Sciences

Agriculture, AgTech, Biotechnology, and Food Processing

US$ 250 million

Memphis Meats

Food & Beverage and Nutrition

US$ 161 million

Connect With Our Research Analyst On: https://www.theinsightpartners.com/speak-to-analyst/TIPHE100000960

Synthetic Biology Market: Segmental Overview

The synthetic biology market, based on product, is segmented into oligonucleotides, chassis organisms, enzymes, and xeno-nucleic acid. The oligonucleotides segment is likely to hold the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the market from 2021-2028. This is mainly because of the rising application of oligonucleotides in genetic testing/ assays and forensic sciences. Based on technology, the market is segmented into, gene synthesis, genome engineering, measurement & modeling, cloning & sequencing, nanotechnology, and others. In 2021, the gene synthesis segment is likely to hold the largest share of the market. However, the genome engineering segment is expected to grow in demand at the fastest CAGR of 20.8% from 2021 to 2028. Based on application, the market is segmented into medical applications, industrial applications, environmental applications, food and agriculture, and others. The medical applications segment is further segmented into drug discovery & therapeutics and pharmaceuticals. In 2021, the medical applications segment is likely to hold the largest share of the market. Moreover, the similar segment is expected to witness growth in its demand at the fastest CAGR of 20.8% from 2021 to 2028.

North America synthetic biology market includes consolidated markets for countries such as the US, Canada, and Mexico. In recent years, all the three countries in the region are witnessing a sequential change in the synthetic biology market. By geography, North America held the largest global synthetic biology market share. This largest share can be attributed to government funds, investments made by the major companies, conferences held for awareness regarding synthetic biology, technological advancements in genomics, and higher consumer acceptance. Synthetic biology is a major tool for biological advances, which helps in providing potential for the development of biological weapons. Security issues can be avoided by regulating the biotechnology industry through policy legislation.

Buy Premium Copy of Synthetic Biology Market Size, Share, Revenue, Strategic Insights and Forecasts 2021-2028 Research Report at: https://www.theinsightpartners.com/buy/TIPHE100000960/

The various government initiatives and funding offered are becoming great support for the synthetic biology market to grow in the US. For instance, according to a report by National Center for Biotechnology Information (NCBI), the US government offers approximately US$ 220 million every year toward synthetic biology research and development.

Browse Adjoining Reports:

Synthetic Biology Technology Market Forecast to 2028 - COVID-19 Impact and Global Analysis ByType (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Microfluidics, Nanotechnology); Application (Medical, Industrial, Food and Agriculture, Others) and Geography.

Oligonucleotide Synthesis Market Forecast to 2027 Global Analysis by Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), and End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users).

Gene Synthesis Market to 2025 - Global Analysis and Forecasts By Products & Services (Services, Consumable, Software), Application (Research & Development Activities, Diagnostics, Therapeutics, Others) End Users (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, Others) and Geography.

Genomics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, and Others), Product & Service (Instruments/Systems, Consumables, and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research, and Others) and End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, and Others).

Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Enzymes and Kits & Reagents), Application (Epigenetics, Sequencing, Synthetic Biology, Polymerase Chain Reaction, and Other), End User (Biotechnological & Pharmaceutical Companies, Hospitals & Diagnostic Centres, and Academic & Research Institutes), and Geography.

Genome Editing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (CRISPR, TALEN, Antisense, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations).

Biohacking Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Sensors, Smart Drugs, Strains, Wearables, Others); Application (Synthetic biology, Genetic engineering, Forensic science, Diagnosis and treatment, Drug testing, Others); End User (Pharmaceutical and biotechnological companies, Forensic laboratories, Others) and Geography.

Enzymatic DNA Synthesis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Custom DNA Synthesis, DNA Library Synthesis); Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, Others); End User (Academic and Research Institutes, Biotech and Pharmaceutical Companies, Diagnostic Laboratories, Other) and Geography.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Sameer JoshiE-mail: sales@theinsightpartners.com Phone: +1-646-491-9876Press Release: https://www.theinsightpartners.com/pr/synthetic-biology-market

Cision

View original content:https://www.prnewswire.com/news-releases/synthetic-biology-market-size-worth-37-85-billion-globally-by-2028-at-20-cagr---exclusive-report-by-the-insight-partners-301532833.html

SOURCE The Insight Partners

Read more here:
Synthetic Biology Market Size Worth $37.85 Billion, Globally, by 2028 at 20% CAGR - Exclusive Report by The Insight Partners - Yahoo Finance

Global Cell Sorting Market 2022 Regional Analysis and Major Manufacturers as Becton, Dickinson and Company, Beckman Coulter, Bio-Rad Laboratories,…

The study Global Cell Sorting Market from 2022 to 2028 looks into worldwide market trends. The goal of MarketandResearch.biz is to give customers a comprehensive perspective of the market and to help them establish development strategies. Based on a thorough and expert analysis, the Cell Sorting makes a prognosis for the years 2022-2028.

The research includes a revenue estimate study for each industry, as well as some background information. The revenue forecast is based on the segments current market performance as well as a quick review of historical data.It focuses on market characteristics in the worldwide market, such as primary drivers, opportunities, limiting factors, and obstacles. Business strategists will benefit from this research because it will help them expand efficiently in both global and regional markets.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketandresearch.biz/sample-request/230316

The market development trends for this industry are then forecasted in this report. Furthermore, the market analysis provides an overview of the global Cell Sorting industry based on a number of aspects, including geographic scope, market segmentation, growth drivers, and market obstacles.

Aside from that, the study provides important data on

It also looks at the key industry vendors that are now accessible.

For example, information on the markets suppliers and distributors. A brief study of end-user sectors, as well as demand forecasts, are also included in the research.

It examines the Cell Sorting market segments in great detail.

It also places a big focus on segment analysis by area.

ACCESS FULL REPORT: https://www.marketandresearch.biz/report/230316/global-cell-sorting-market-growth-status-and-outlook-2022-2028

It helps clients better understand the regional performance of the Cell Sorting market by evaluating substitute threats, competition intensity, the threat of new entrants, buyer and supplier power, as well as the markets strengths, weaknesses, threats, and opportunities.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketandresearch.biz

More here:
Global Cell Sorting Market 2022 Regional Analysis and Major Manufacturers as Becton, Dickinson and Company, Beckman Coulter, Bio-Rad Laboratories,...

Biotechnology and Pharmaceutical Services Outsourcing Market Report Covers Future Trends With Research 2022 to 2029 IQVIA, The Quantic Group, Lachman…

Biotechnology and Pharmaceutical Services Outsourcing Market research report is the new statistical data source added by Research Cognizance.

Biotechnology and Pharmaceutical Services Outsourcing Market is growing at a High CAGR during the forecast period 2022-2029. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Biotechnology and Pharmaceutical Services Outsourcing Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share, and contact information are shared in this report analysis.

Get the PDF Sample Copy (Including FULL TOC, Graphs, and Tables) of this report @:

https://researchcognizance.com/sample-request/474

Top Key Players Profiled in this report are:

IQVIA, The Quantic Group, Lachman Consultant Services, Inc., Parexel International Corporation, Concept Heidelberg GmbH, GMP Pharmaceuticals Pty Ltd., Charles River Laboratories, Covance Inc.

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Biotechnology and Pharmaceutical Services Outsourcing market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Biotechnology and Pharmaceutical Services Outsourcing markets trajectory between forecast periods.

Get up to 30% Discount on this Premium Report @:

https://researchcognizance.com/discount/474

Regions Covered in the Global Biotechnology and Pharmaceutical Services Outsourcing Market Report 2022: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

The cost analysis of the Global Biotechnology and Pharmaceutical Services Outsourcing Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Biotechnology and Pharmaceutical Services Outsourcing market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Biotechnology and Pharmaceutical Services Outsourcing market.

Buy Exclusive Report @:

https://researchcognizance.com/checkout/474/single_user_license

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Research Cognizance is an India-based market research Company, registered in Pune. Research Cognizance aims to provide meticulously researched insights into the market. We offer high-quality consulting services to our clients and help them understand prevailing market opportunities. Our database presents ample statistics and thoroughly analyzed explanations at an affordable price.

Contact Us:

Neil Thomas

116 West 23rd Street 4th Floor New York City, New York 10011

sales@researchcognizance.com

+1 7187154714

Read this article:
Biotechnology and Pharmaceutical Services Outsourcing Market Report Covers Future Trends With Research 2022 to 2029 IQVIA, The Quantic Group, Lachman...

Asthma, allergy risk may be higher for children conceived with infertility treatment – National Institutes of Health (.gov)

News Release

Thursday, April 21, 2022

Children conceived with infertility treatment may have a higher risk for asthma and allergies, suggests a study by researchers at the National Institutes of Health. The study was conducted by scientists at the Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Institute of Environmental Health Sciences, part of the National Institutes of Health. It appears in Human Reproduction.

The study enrolled approximately 5,000 mothers and 6,000 children born between 2008 and 2010. Mothers responded periodically to questionnaires on their health and their childrens health and medical histories. Infertility treatments included in vitro fertilization (sperm and egg are combined in a laboratory dish and inserted in the uterus), drugs that stimulate ovulation, and a procedure in which sperm are inserted into the uterus.

Compared to children conceived without infertility treatment, children conceived after treatment were more likely to have persistent wheeze by age 3, a potential indication of asthma. At 7 to 9 years old, children conceived with treatment were 30% more likely to have asthma, 77% more likely to have eczema (an allergic condition resulting in rashes and itchy skin) and 45% more likely to have a prescription for an allergy medication.

The authors called for additional research to determine how infertility treatment or lower parental fertility might influence the development of asthma and allergy in children.

Edwina Yeung, Ph.D., of the NICHD Epidemiology Branch and senior author of the study, is available for comment.

Polinski KJ et al. Infertility treatment associated with childhood asthma and atopy. Human Reproduction. 2022.https://doi.org/10.1093/humrep/deac070

About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. For more information, visit https://www.nichd.nih.gov.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Read more:
Asthma, allergy risk may be higher for children conceived with infertility treatment - National Institutes of Health (.gov)

Publicly-funded IVF to begin in 2023 with ‘regional fertility hubs’ before that – TheJournal.ie

THE DEPARTMENT OF Health is planning to fund IVF services from 2023, with Taoiseach Michel Martin saying today that regional fertility hubs will be established before that.

A public fund which promised financial support for people undergoing fertility treatmentwas first announced in 2017, with commitments to fund IVF also contained in the Programme for Government.

Earlier this year, the government published the Health (Assisted Human Reproduction) Bill which will provide a basis for infertility services but no strict timeline for public IVF was provided.

It has now been confirmed by the Department of Health that it is hoped this would come on stream in 2023.

Speaking in the Dil today, Martin said Minister for Health Stephen Donnelly increased funding for womens health in this years Budget.

The minister intends to have a model of care for infertility, which will see the introduction of advanced assisted human reproduction treatments, including IVF, in the public health system. Mr Donnelly plans to commence this in 2023.

Currently, Ireland is the only country in the European Union where fertility treatments such IVF are not publicly funded.

Martin was speaking in the Dil today in response to questions from People Before Profit TD Paul Murphy, who has spoken publicly about the cost of IVF treatments for himself and his partner.

Murphy noted that there have been promises from previous governments about IVF funding and that he was doubtful whether it would happen next year.

I dont want to hold my breath about it, because we have heard this before, from the then minister for health Leo Varadkar in 2016, its in Slintecare, its in the Programme for Government and there has been precious little progress, he said.

So Im asking Taoiseach for a guarantee that this is actually going to happen in 2023 and a timeframe for when that will be within that year. Im also asking for a commitment that sufficient funding will be provided for the public system to ensure it can be done publicly, as opposed to outsourced private, mostly for-profit providers.

The question of the private companies profiting from infertility treatments is one that has been investigated by Noteworthy, with some private facility clinics reporting profits of well over 1 million in financial statements.

Speaking today, Fine Gael TD Neale Richmond also told the Dil that publicly available IVF must be matched but statutory employee leave to attend appointments.

What preparatory work has begun in relation to ensure that both parents will be eligible for leave dates and sick leave dates during this period, that eligibility will be inclusive of all of society?, he said.

Can we ensure that this process will be open and accessible to all very quickly because the uncertainty is already playing on so many hearts and minds of people around the country.

Taoiseach Michel Martin noted that theAssisted Human Reproduction Bill passed its second stage in March and continues to work its way through the Oireachtas.

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Phase One of the rollout of the model of care has involved the establishment at secondary care level of regional fertility hubs within maternity networks in order to facilitate the management of a significant proportion of people presenting infertility issues at this level of intervention, he said.

Phase Two of the rollout will see the introduction of tertiary infertility services, including IVF, in the public health system planned for 2023 at such time as infertility serves a secondary level services have been developed across the country.

The key legislation, the Assisted Human Reproduction Bill, passed second stage on 23 March, has been referred to the Select Committee on Health for third stage. Its important to get that through to create the legislative base.

Excerpt from:
Publicly-funded IVF to begin in 2023 with 'regional fertility hubs' before that - TheJournal.ie

Regulating domestic surrogacy in Ireland: Is the process too perilous for intended parents? – BioNews

25 April 2022

Assistant Professor at the National University of Ireland, Galway

The Health (Assisted Human Reproduction) Bill 2022 was published in March 2022, and is currently being considered by the Irish Parliament. Part seven provides for the regulation of altruistic, domestic surrogacy arrangements. However, it does little to encourage intended parents to enter into such arrangements, because it proposes a complex, hybrid pre and post-birth model for regulating domestic surrogacy.

The Bill provides for the setting up of an Assisted Human Reproduction Regulatory Authority (AHRRA) that must, among its many functions, approve the parties' surrogacy agreement before any treatment in a clinic will be permitted. However, despite all parties having received implications counselling and independent legal advice regarding the agreement by this time, the AHRRA's pre-conception 'approval' of their agreement will be limited to the approval of treatment, not legal parentage of the surrogate-born child.

The Bill provides that the gestational surrogate will be the child's legal mother at birth (the Bill only proposes to regulate gestational surrogacy). The intended parents can only apply to the court seeking a parental order transferring legal parentage from the surrogate a minimum of 28 days after the birth of the child. The surrogate must consent to this transfer of parental rights or she will remain the child's legal mother, and there appears to be nothing that the intended parents can do about this. Part seven makes it clear that the surrogate's consent can only be dispensed with by the court if she is either deceased or cannot be located.

This requirement around consent is a retrograde step when compared to the original draft of the Bill that was published as far back as 2017. In the General Scheme of the Assisted Human Reproduction Bill 2017, it was provided that the court could waive the requirement for the surrogate's consent to a parental order 'for any other reason the court considers to be relevant' which, if it had been retained in the current Bill, would at least have offered a potential life-line to intended parents who might find themselves in a predicament where the surrogate refuses to consent to a parental order. Indeed, one wonders whether this provision was intentionally removed from the Bill to make domestic surrogacy as perilous an undertaking as possible for Irish intended parents.

The Bill was drafted by the Department of Health and, as regards surrogacy, little has changed from the provisions in the General Scheme in 2017. This is surprising when one considers developments that took place in the interim period between the General Scheme and the Bill. In 2019, the two Law Commissions in the UK published a Consultation Paper proposing a move away from the 'Post-Birth Parental Order' model for regulating domestic surrogacy arrangements in that jurisdiction to a 'Pre-Conception Approval' model for determining legal parentage in favour of intended parents at birth.

However, it is clear from the above discussion that the post-birth aspects of the regulatory model proposed in the Irish Bill mirror unsatisfactory aspects of the current UK model, particularly in the area of post-birth consent. In 2020, Professor Conor O'Mahony, Ireland's special rapporteur on child protection, submitted 'A Review of Children's Rights and Best Interests in the context of Donor-Assisted Human Reproduction and Surrogacy in Irish Law', which also proposed a pre-conception approval model for determining legal parentage in cases of domestic surrogacy in Ireland.

It is worth noting that a pre-conception model for approving legal parentage of the surrogate-born child in favour of the intended parents might not only encourage them to avail of domestic surrogacy rather than going abroad, but it would also establish the child's right to family life with its intended parents immediately at birth. Further, this would not conflict with the surrogate's right to manage her pregnancy the same as any other woman because legal parentage would only arise in favour of the intended parents by operation of law at birth.

Nonetheless, the Bill does not allow for this approach intended parents will have to soldier on after their agreement is approved by the AHRRA in the hope that the surrogate will be willing to consent to the transfer of legal parentage to them by a court after she gives birth. While evidence indicates that the vast majority of surrogates do not view themselves as the mother of the child they have gestated for the intended parents, this is likely to be of little comfort to intended parents when deciding whether or not to embark on a pathway to parenting that involves substantial emotional investment, some financial investment, various pre and post-birth legal and administrative processes, and a degree of risk regarding the ultimate legal parentage of the surrogate-born child.

It is unclear why the State is wedded to the post-birth parental order model for regulating legal parentage in the context of domestic surrogacy. It is certainly not required by the Constitution or case law from the Irish superior courts, because in 2014 the Supreme Court made it clear that the regulation of surrogacy arrangements is a complex matter of social and public policy to be dealt with by the Irish Parliament, and that the principle of 'mater semper certa est (motherhood is certain)' is not part of the common law of Ireland.

Nonetheless, it is possible that a further, significant development influenced the State's decision the report of the United Nations (UN) 'Special Rapporteur on the sale and sexual exploitation of children'. In her report in 2018, the then UN Special Rapporteur advised nations that 'to prevent the sale of children in the context of altruistic surrogacy' and avoid a breach of the UN Convention on the Rights of the Child 'Optional Protocol on the sale of children, child prostitution and child pornography', the surrogate must 'retain parentage and parental responsibility at birth', and be under no legal obligation to transfer the child.

According to the UN Special Rapporteur, the surrogate's choice after the birth to transfer the child to the intending parents must be a gratuitous act, based on her own post-birth intentions, rather than on any legal or contractual obligation. Indeed, this might be the reason the Bill provides that the surrogate's post-birth consent can only be dispensed with by a court in the two abovementioned, extreme circumstances. If so, then the Bill is according too much weight to international law to the detriment of the constitutional rights of the child.

Indeed, Ireland has not yet even ratified the Optional Protocol on the sale of children, child prostitution and child pornography. However, children's rights are expressly protected in Article 42A of the Irish Constitution. Thus, it is imperative that a child-centred reason for waiving the need for the surrogate's consent to a parental order should be provided in the Bill.

In the context of an adoption, Section 31 of the Adoption Act 2010, as amended, allows the High Court to dispense with the need for the natural mother's consent where she fails, neglects or refuses to give her consent to the making of an adoption order. However, before doing so the High Court must have regard to 'the rights, whether under the Constitution or otherwise, of the persons concerned (including the natural and imprescriptible rights of the child)' under Article 42A.

One such 'natural and imprescriptible' constitutional right of a surrogate-born child might surely be a right to the enjoyment of family life with its intended parents, at least one of whom will be genetically related to the child according to the Bill, and both of whom are responsible for its birth by initiating the surrogacy arrangement? If legislation can allow a natural mother's consent to an adoption to be dispensed with in the manner above, surely it should similarly allow a gestational surrogate's consent to possibly be dispensed with on the same grounds?

In its current form, the approach to domestic surrogacy in the Health (Assisted Human Reproduction) Bill 2022 is restrictive and risk-laden, and thus unlikely to encourage many intended parents to avail themselves of surrogacy in Ireland. Many will most likely continue to go to commercial surrogacy jurisdictions where their legal parentage can be recognised at birth. In that regard, it should be noted that while the Bill contains no provisions on recognising the parentage of children born via international surrogacy, a parliamentary committee is currently exploring options for legislating in this area.

Here is the original post:
Regulating domestic surrogacy in Ireland: Is the process too perilous for intended parents? - BioNews

Microfluidic 3D Bioprinting Allows a Better Reproduction of Cell Structures – 3Dnatives

At the Stevens Institute of Technology in the United States, a team of researchers is currently working on the development of a bioprinting method based on microfluidics. This microfluidic bioprinting is a technique that manipulates fluids with characteristics in the micrometer range. The interesting part of it is that this project would give researchers the ability to work on a much smaller scale than ever possible before, even allowing for the creation of any type of human tissue. Researchers could reproduce the biological characteristics of human body cells very precisely thus advancing, for example, organ transplants.

Led by Professor Robert Chang, the team has developed a computational model to accelerate microfluidic bioprinting and enable organ development. According to the Division of Transplantation (DoT) of the Health Resources and Services Administration at the U.S. Department of Health and Human Services, there are currently 105,940 people on the national transplant waiting list. The lack of available organs for transplants is fatal for people across the country, and this issue could possibly be solved thank to 3D printing. As you probably know, bioprinting is able to reproduce customized cellular structures to facilitate the creation, for example, of skin or even organs. Though we are still far from obtaining a 3D printed heart or a fully functional kidney, as this latest advancement has clearly shown, progress is real.

Microfluidics is a science that manipulates fluids with characteristics in the micrometer range

The research conducted by the research of this American team could tip the balance. That is especially because it is based on microfluidics. Other 3D bioprinters on the market are mainly based on extrusion, which are extruding inks layer by layer with a thickness of about 200 microns. However, thanks to microfluidic bioprinting, it would be possible to go down to only a few tens of microns and in that way have a scale much closer to that of the cell itself. Robert Chang explains: Creating new organs to order and saving lives without the need for a human donor will be an immense benefit to healthcare. However, reaching that goal is tricky because printing organs using bio-inks hydrogels laden with cultured cells requires a degree of fine control over the geometry and size of printed microfibers that current 3D printers simply cant achieve.

By getting as close as possible to the scale of human cells, the team would be able to reproduce more detailed biological characteristics of each one. The team has developed a computer model of a microfluidic print head, to control parameters such as flow speed and fluid dynamics. This model allows it to modify the geometries and material properties of the bioprinted structure. Above all, it offers the possibility of mixing several bio-inks, and therefore several types of cells, to design more complex organs.

Current 3D bioprinters are mainly based on an extrusion process (photo credits: Dpartement06-Xavier Giraud)

So far, the researchers say they have printed bladders using 3D printed scaffolds. But by combining multiple bio-inks, they hope to go much further. Robert Chang concludes, Being able to operate at this scale, while precisely mixing bio-inks, makes it possible for us to reproduce any tissue type. This technology is still so new that we dont know precisely what it will enable. But we know it will open the door to creating new structures and important new types of biology.

While waiting for further developments, you can visit the Stevens Institute website HERE. What do you think of this microfluidic bioprinting method? Let us know in a comment below or on ourLinkedin,Facebook,andTwitterpages! Dont forget to sign up for our free weeklyNewsletter here, the latest 3D printing news straight to your inbox! You can also find all our videos on ourYouTubechannel.

See the original post:
Microfluidic 3D Bioprinting Allows a Better Reproduction of Cell Structures - 3Dnatives

Deves said surrogacy is reproductive prostitution and violates human rights – Sydney Morning Herald

In another tweet, from September, Deves replied to journalist Georgie Dent, who had quoted an opinion piece published in the Herald and The Age accusing Morrison of an act of chutzpah for reserving the keynote address at the National Womens Safety Summit.

Maybe he [Morrison] identifies as a woman? Deves quipped.

Deleted tweets from the account of Liberal candidate for Warringah, Katherine Deves.Credit:Internet

The NSW Liberal Party was contacted for comment. Deves has previously issued apologies for the language she has used in conducting her campaign, as well as for any hurt caused, though she did not resile from her beliefs.

Morrison was not asked directly about Deves surrogacy comments at his daily election campaign press conference on Thursday but continued to defend her and said he had spoken to her earlier with words of encouragement.

Loading

Katherine is campaigning and Ive been in contact with Katherine again today encouraging her, Morrison said.

He also denied leaking a text message from NSW Premier Dominic Perrottet expressing support for Deves, suggesting it could have been leaked by one of the close colleagues he had spoken with about the matter.

When I was speaking to some close colleagues in the Liberal Party on the weekend, they asked me whether Dom had been in contact, and I simply said that he had, Morrison said on Thursday.

I hadnt shared any text messages or anything like that, I just said he had been in contact. We didnt and they didnt [leak the message].

Deves was the prime ministers hand-picked candidate for the seat amid an internal Liberal stalemate over candidate preselections in NSW. Nominations closed on Thursday, with Deves now certain to appear on the ballot paper.

Treasurer Josh Frydenberg was asked about some of Deves recently-revealed comments while he was campaigning with Liberal MP Trent Zimmerman.

There is a legitimate discussion that has been had by the community about participation in sport, having a level playing field, Treasurer Josh Frydenberg said. But as for [Deves] comments, they were inappropriate, insensitive, unacceptable.

She cancelled a scheduled appearance at a community forum in Manly on Tuesday night where she was due to appear alongside other candidates including incumbent MP Zali Steggall.

It followed days of coverage of Deves comments about transgender issues in tweets and videos, including calling LGBTQ initiative Wear It Purple Day a grooming tactic, saying trans children were surgically mutilated and speculating Canadian actor Elliot Page was paid to come out as transgender.

Original post:
Deves said surrogacy is reproductive prostitution and violates human rights - Sydney Morning Herald

Fantasies of Whiteness – Architecture – E-Flux

At the inauguration of the First Brazilian Congress of Eugenics in July of 1929, the physician and anthropologist Edgar Roquette-Pinto addressed an audience preoccupied with the question of how a country as vast as Brazil could best increase and improve its population. To accomplish this, Roquette-Pinto exalted eugenia as the new science that, together with medicine and hygiene, would guarantee the efficiency and perfection of the race. With the following words, the Brazilian scientist underscored a positivist agenda that brought architecture to the very core of the eugenicsthe so-called science of race improvementmovement: It is critical to emphasize that the influence [on our race] does not stem from the natural environment but rather from the artificial environment, created by man. With these opening remarks to the Congress, Roquette-Pinto called attention to the crucial role that the man-made environment plays in the amelioration of what he called the biological patrimony of Brazils diverse population. In his invitation to social engineering, Roquette Pinto pointed to the environmental-genetic collusion that they hoped would bring with it the very possibility of progress.

This story begins at a critical global moment in which medical scientific discourses, first articulated in France, crossed the ocean and became intertwined with discourses of architecture, landscape, urban planning, and aesthetics in early twentieth century Brazil. At the epicenter of this ideological encounter were two influential global movements, hygienics and eugenics, which became the dual vehicles for bringing architecture into active dialogue with social engineering. Conceived as a comprehensive program of reform for reconstituting and reorganizing human life, hygienics prescribed the control of human behavior, the abatement of harmful bacteria and diseases, the supply of clean water and air, and the provision of open space. And eugenics, the social and biological movement that strove for nothing less than the improvement of the human race, instrumentalized heredity and the environment. The form of eugenics adopted in France, and then in Brazil, was based on French naturalist Jean Baptiste Lamarcks theory of the inheritance of acquired characteristics, wherein evolution was driven by adaptation to environmental changes, in contrast to Mendelian eugenics, which viewed evolution as impervious to the environment and driven solely by genetics. In fact, French ideas and practices of eugenics took root well before Francis Galton coined the very term eugenics (from the Greek , meaning well-born) in 1883 to define the modern science that deals with all influences that improve the inborn qualities of a race; also with those that develop them to the utmost advantage. Fueled by increasingly urgent fears of degeneration, French physicians visualized medicine as the very apparatus capable of regulating reproduction and disciplining society.

In modern Brazil, a region so culturally and scientifically influenced by France, and where medicine and the built environment were targeted as primary mechanisms of un-underdeveloping the population, it is no surprise that Lamarckian eugenics acted as a pervasive agent of modernity. The medicalization of bodies and spaces led to a normative program in which determinismof race, gender, and the environmentcontributed to the implementation of a system of exclusion that was legitimized by science and materialized by architecture. The simultaneous construction of a white heterosexual society as the normal and desirable one, and of a healthy and modern environment that would contribute to this normalization, consolidated the clinical agenda of architectural modernism. Although this strategy was central to modernism at large, a specific transatlantic and interdisciplinary network of global actors, scientific theories, and spatial practices placed architecture at the center of the eugenics agenda of white supremacy.

Influenced by the power of medical science and architectures instrumentalization of natureeverything from the sun to the wind and the treesin the reimagining of society, hygienic and eugenic practices became complicit in the process of constructing modern nations in the new world. In Brazil, the nation was seen as a sick organism, and reformersincluding social scientists, architects, and urban plannerswere tantamount to physicians with the responsibility of diagnosis and treatment. In the center of Rio de Janeiro, this mission brought together a diverse cast of characters: from the physicians and architects of the Parisian Muse Social, the early French think-tank that sought to undertake Frances pressing social question, to the physicians and architects of Rio de Janeiro who formulated the theories, practices, and ethos of Brazilian modernism, to Le Corbusier, who began consolidating a eugenicist ideology precisely during the months he spent in Brazil in the mid-1930s.

In the early 1920s, even before the First Brazilian Congress of Eugenics took place, a dramatic event occurred in Rio. The battle against bubonic plague, yellow fever, and other tropical diseases had led to a sanitary and urban reform that reached its climax with the demolition of an entire populated mountain, the Morro do Castelo, in the center of the Brazilian capital. This mountain was no ordinary mountain; it was the original site where the colonial city, with its historical buildings and underground infrastructure, had been established in 1567. But the idea of eliminating the mountain was not new. As far back as 1798, a medical report had argued for the mountains demolition, since according to the author it acted as an enormous barrier that blocked the circulation of air from the sea and consequently facilitated the proliferation of diseases. But it was not until the 1920s, when aesthetic and moral imperatives were added to sanitary ones, that the mountain came to be seen as the very negation of modernity itself; a reservoir of vice and disease with a motley marginal population, including poor Blacks and formerly enslaved people who, according to the elites, invaded the center of the city with their embarrassing practices of superstition and misery. At that time, medicine became the principal tool used by elites to study and then reconfigure their national populations. It was only when hygieneuntil then understood as personal or environmentalbecame social hygienean economic science concerned with the outputs of human capital (production and reproduction)that the demolition of the Morro do Castelo became possible. The demolition represented the first and most radical action in the construction of a new national image, free of backward associations and racial exoticism.

The extensive territory that resulted from this demolition was immediately occupied by the 1922 International Exhibition. Commemorating the one hundredth anniversary of Brazils independence, the exhibition was conceived as a self-portrait of a modern nationa nation that undertook a self-remaking process, not only of its milieu but also of its population. Promoting itself as a tabula rasa, the exhibition represented a literal triumph over the territorya territory now cleansed of its history and unwanted inhabitants. Its more than 500-page catalog is striking in its complete elimination of all traces of the African and indigenous components of Brazilian culture. With the exception of one article briefly mentioning the abolition of slavery, the catalog presents Brazil as a white country. Its images demonstrate a new alliance between beauty, health, tropicality, and modernization that Brazilian elites adopted to represent themselves and their new nation. In most publicity materials, white men, women, and children of classic Greco-Roman appearance wearing red or white robes and crowns were arranged against European-looking hills and gardens to frame the architecture and machinery of modern factories.

Just as human beings were portrayed as icons of the ideal, so too were natural monuments released from their tropical fatality, politicized as new icons of collective identity and moralized as elements of transformation. In several advertisements, the catalog exalted the natural monuments of Rio de Janeiro, particularly those human-made or human-dominated. An advertisement for a medication, for instance, portrays the Po de Acar as one of the Seven Wonders of the World. The catalog also celebrates Corcovado, the extraordinary mountain at the center of the Tijuca Forest and the worlds largest human-made urban rainforest which, only a few years later, would be crowned with a monumental forty-meter-tall statue of Christ the Redeemer. Razing the Morro do Castelo while transforming two other mountains within the city into sites of pure aesthetic pleasure, tropical naturenow monumentalizedis portrayed precisely as a site of interplay between the body, labor, and technology.

The exhibition not only represented a triumph over nature, but a triumph over degeneration. In fact, the First Brazilian Congress for the Protection of Infants, an essential part of the exhibition, was an agent of Brazils transformation of puericulture, the French faith-based science, into a neo-Lamarckian form of eugenics. Revealing the influence of French medicine on Brazilian medical circles, debates in the Congress focused on the importance of puericulturethe term that Adolphe Pinard, the French physician and member of the Parisian Muse Social revitalized as an human analogue for agriculture for the scientific cultivation of the mother-child unit. Echoing Pinard, Brazilian physicians were convinced that a child was the result of two forces in equilibrium: heredity and milieu, and that consequently puericulture was one of the most accessible ways of conserving and perfecting the human species while also whitening the population.

Just as the exhibition catalog was overrun by Hellenic-looking people, the demolished mountains footprint was suddenly overrun by neo-colonial pavilions. Shortly after the exhibition, in 1922, and lasting until 1938, neo-colonial architecture was declared by the government to be the national style, mandatory for every building that would represent Brazil abroad. This need to present modern Brazil as a homogeneous white society needs to be seen alongside the omission of race as a demographic factor in every national census from 1890 to 1940, which was not the result of a need to promote a race-neutral society, but an explicit expression of the fantasy of a much-desired white Brazil.

The adoption of neo-colonial architecture was followed a few years later, in 1926, by an invitation to French Beaux-Art architect and member of the Muse Social Donat-Alfred Agache to formulate an urban plan for the Morro de Castelo esplanade in this visual language that Brazilian elites had come to identify as their own. Neo-colonial and Beaux Art styles were interchangeable as representations of the visual ideology of the country, and Agaches invitation suggests a telling complicity between science and aesthetics in the practices of physicians and architects. Agaches proponents in Brazil were largely physicians who supported the neo-Lamarkian ideas proclaimed at the Muse Social, where both Pinard and Agache were active members. Although Brazilian elites were not a homogeneous group, they seemed to agree on the image they wanted for their cities. Even Mario de Andrade, one of the main protagonists of the Semana de Arte Moderna in So Paulo, who celebrated Brazilian identity as a mixture of the European, indigenous, and African, as well as Lucio Costa, the architect of Brasilia, the modern capital ex-nihilo of Brazil, were both open supporters of Jose Mariano Filho, the Brazilian physician who became the most vehement promoter of neo-colonial architecture and the main advocate for the appointment of Agache.

In 1928, in a series of articles published in Dirio Nacional, Andrade celebrated the role of architects working for the normalization of the neo-colonial as a Brazilian national style. In many ways, these modern attitudes sought to homogenize the city and its population by eradicating undesirable inhabitants and proclaiming the esplanade to be a political and economic altar to power, infused with white European forms. It was not a coincidence that all thisthe demolition of the mountain, the elimination of Rio de Janeiros original urban nucleus, the displacement of its poor residents, and the construction of the exhibition pavilionswas executed almost simultaneously with new policies and mandates such as the white only decree of 1921, which prohibited the immigration of Blacks to Brazil.

Why did the organizers of this exhibition select the neo-colonial style to represent their new modern country in the centennial anniversary of its independence? In other words, what do these two imageswhite people and neo-colonial architecturehave to do with one another? No one illustrates this connection between race and architecture better than Lucio Costawho, in 1928, made this racist link in a newspaper article:

I am pessimistic about architecture and urbanism in general. All architecture is a question of race. When our nation is that exotic thing that we see on the streets, our architecture will inevitably be an exotic thing. It is not those half dozen who travel and dress on Rue de la Paix, but that anonymous crowd that takes trains from Central [Station] and Leopoldina, people with sickly faces who shame us everywhere. What can we expect from people like this? Everything is a function of race. If the breed is good, and the government is good, the architecture will be good. Talk, discuss, gesticulate: our basic problem is selective immigration; the rest is secondaryit will change on its own.

Thus, the neo-colonial style, which was in a sense anti-modernist, pro-Iberian, and white was appropriated as the emblem of progress and modernitysuggesting a clear link between colonialism and modernism. Costa intended for his eugenic syllogism of breed-begetting-good-government-begetting-good-architecture to also work in reverse.

When Le Corbusier traveled for the second time to Brazil in 1936, his discourses were centered on nature, death, and the racial and sexual other. The fear of degeneration that had haunted French society for decades, and a sense of impending death inhabited modernity. For him, no other place represented this decay better than Rio de Janeiro, with its black population and exotic tropical landscape. From the early 1930s, as an antidote to this irrevocable decay, Le Corbusier endorsed puericulture as a means of improving the quality of newborns and managing defective infants. As a Lamarckian of his time, he was convinced that the well-being of the child was linked to the mothers health and lineage, as well as to environmental influences. Le Corbusier intertwined pronatalist outlookswhich emphasized the traditional reproductive role of women in the familywith the built environment in which reproduction, maternity, and child rearing occurred. In a 1931 article published in the neo-syndicalist journal Plans, he called for the establishment of special nurseries directly connected to every single dwelling, run by qualified nurses and supervised by doctors: [to provide] security-selection-scientific child rearing[in other words] puericulture. A year later, he introduced the fourth section of an unpublished article with the conjoined term eugenisme-puericulture. His insistence on seeing eugenics and puericulture as inseparable continued for the next decade, ultimately claiming that Eugenics [and] puericulture will ensure a well-bred race. Within this context, Le Corbusier came to believe not only that there was an intimate connection between architecture, health, and the perfection of the human race, but that he had been chosen as the primary agent to materialize this coalescence.

In 1936, while preparing his series of talks in Rio de Janeiro, Le Corbusier made a sketch on a piece of cardboard that distilled and concretized one of the most basic and accepted rationales of modernity: change the environment, change the man. Written at the top is the word Castello, followed by the name Lucio Costa, the phrases pedro aller police and Castello cots clichs, the name of architect Carlos Porto, and the phrase Acheter livre Carrel. The latter was a reminder for him to buy the new bestseller by the French Nobel prize-winning physician Alexis Carrel, Man The Unknown, an unmistakable call for the implementation of eugenics and manifesto for white supremacy. What made Le Corbusier think of Carrel while thinking of Rio de Janeiro? It is not a mere coincidence that Castelo, one of the most significant eugenic laboratories in Latin America, is the first word that appears on the cardboard. But Castelo was not only the name of the pulverized mountain from which thousands of undesirable inhabitants had been displaced, or the stage for the 1922 international exhibition with its neocolonial pavilions and its image of white Brazil, or the epicenter of the master urban plan that Agache had designed for Rio. Castello was also where Lucio Costa was designing the new building for the Ministry of Health and Education, the institution charged with developing and enforcing Brazils eugenic policies under Getulio Vargas new authoritarian regime, for which Le Corbusier had been invited to be a design consultant. This sketch links the dramatic transformation of the urban territory of Rio de Janeiro to Lucio Costas project and to Carrels vision for remaking society, along with the representation of a simple man, the ultimate object of transformation. For Le Corbusier, architecture was a tool for social engineering, an optimum medium for the rebirth of the human body.

The association between Carrel and the built environment would become the launch point for much of Le Corbusiers thinking over the next several years. But it was in Rio during that summer of 1936 that Le Corbusier directly aligned himself with Carrels ideas. In his first talk, evoking Carrels book, Le Corbusier commented to his audience:

Plon, the editor who published my book [When the Cathedrals Were White] in North America, celebrates the success of his latest book: Man, The Unknown by Dr. Carrel. Write, he told me, a book that will be an echo of that one; I will do it with pleasure: the man and his shell, in other words, the habitus in which a man is obliged to pass a great portion of his life

This appears to be the very first time Le Corbusier made public reference to Carrel and his work. But the cardboard note, where he linked Carrel to Rio de Janeiro with the sketch of a man, was the spark for new theories that would become a viable doctrine for remaking man via nature, through which the built environment would be put to work.

Le Corbusiers book La Maison des hommes (The House of Men), co-authored with Franois de Pierrefeu and published by Plon during the Vichy regime, is this echo of Carrels project for the remaking of society. The book begins with a stated connection between race and architecture: It is over twenty years since, from every rostrum in France, the most authoritative voices raised the cry: We must build new houses, the future of our race depends on how it is housed. The book continues, claiming the redeeming power of the built domain to create the necessary transformation of home life, or to infuse into it order, fecundity. In the tone of a manifesto, the book emphasizes how remaking life is completely dependent on how humans are housed, whether in domestic dwellings, the workplace, the city at large, the countryside, or the metropole.

In his Oeuvre complte 1934-1938, Le Corbusier included a sketch of the Brazilian Ministry of Health and Education building. This new ministry, which later became the symbol of Brazilian modernism, shows an open courtyard surrounded by pilotis and orderly tropical palms. At its center is a colossal sculpture of a seated man with a strong, well-defined body and a tiny head. Gustavo Capanema, the first Minister of Health and Education, had commissioned both the building, which he called the Ministry of Man and was destined to prepare, compose, and perfect the Brazilian man, and the sculpture, which he wanted to embody the ideal Brazilian man that the state itself was directed to produce. Personally invested in finding a tangible image for the ideal Brazilian genotype, Capanema pondered, How will the body of the Brazilian man be, of the future Brazilian man, not the vulgar man or the inferior man but the best exemplar of the race? How will his head be? His color? The shape of his face? His physiognomy?

For Capanema, this sculpture would not simply be a work of art but rather a scientific tool to establish the Brazilian type: the ideal figure that would be legitimate to imagine as representative of the future Brazilian human being. To achieve this goal, Capanema looked to science. First, he turned to Francisco Jos de Oliveira Viana, one of the main voices of the whitening thesis, which argued that by mixing blacks and mulattos with whites, darker skin and black features would be filtered. Capanema also consulted with other scientists such as Juvenil da Rocha Vaz, lvaro Fres da Fonseca, and Edgar Roquette-Pinto. These scientists responses to Capanemas questions were extensively argued and supported by their own scientific studies, but they all agreed that the representation of the Brazilian man should be a white man. Roquette-Pinto in particular proposed the adoption of one of the Leucodermos, an anthropological term he used to classify the predominant type of whites in Brazil. He suggested a white man with dark enough skin to look Mediterranean; the white that would more easily acclimate to Brazil. According to Roquette-Pinto, the Leucodermo was the racial type toward which the morphological evolution of the Brazilian population was marching.

Following Lucio Costa and Le Corbusiers suggestion, Capanema asked the Brazilian artist Celso Antnio to produce the twelve-meter-high granite statue at the entrance of the ministry building. But Antnio objected to designing a figure like the one described by the scientists. He believed the Brazilian man should be the one he observed on the streets. In response, Capanema, disgusted by the mestizo of rough feature that was taking shape in [Antnios] atelier, invalidated the agreement with Antnio and held a competition to select an artist who would take over the design of the statue. The statue was never built, but the pressure to define the ideal Brazilian man remained on the Ministrys agenda, and the building itself, which was created to transform a simple man into the Brazilian man, became the very embodiment of modernity.

When Le Corbusier came back to France and began collaborating with Alexis Carrell under the Vichy regime, his vision of a clinically inspired habitat where all human needs can be met reached a new level of specificity. For over a decade, Le Corbusier had looked for opportunities to assume the role of the techno-social international expert, a tradition initiated by Muse Socials technocrats who, working for France and other nations, produced master plans for cities and villages in the so-called Latin world. He was convinced that the human body, the anatomo-politics of its productivity, and the built environment should be managed by the State. In a 1941 broadcast he affirmed that The housing problem is the key to both the familys regeneration and the spirits regeneration, the key to the nations regeneration. Collapsing milieu and heredity, he affirmed, The degeneration of the house, the degeneration of the family, are one.

For the remainder of that decade, Le Corbusier worked on universalizing the last and most blatant vestige of his modernist ideology. The Modulora term Le Corbusier invented from the word module and the notion of the golden sectioncame to life in 1946 as a way to epitomize the fruits of his doctrine. Bridging both the metric and Anglo-Saxon systems, he conceived the Modulor as a six-foot high man with legs firmly rooted and an outstretched arm. Intended as a human model for scaling all aspects of architecture, Le Corbusiers Modulor became an antidote to disorder, an organizational scheme that infused regularity and normativity into architecture. Its overly large hands and feet, so emblematic of primitivism in modern art, references Le Corbusiers early sketches in Brazil. Representing a map of Le Corbusiers own history and his embrace of evolutionary theories, his pursuit of order, normativity, and purity, the Modulor is an enduring global symbol of architectures past complicities with Lamarckian eugenics.

See the original post:
Fantasies of Whiteness - Architecture - E-Flux